Market Value166,345,000
Total Holdings29
File Date2021-11-04
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
SHC / Sotera Health Company
LRMR / Larimar Therapeutics, Inc.
KYMR / Kymera Therapeutics, Inc.
MDT / Medtronic plc
HZNP / Horizon Therapeutics Plc
DICE / DICE Therapeutics Inc
PMVP / PMV Pharmaceuticals, Inc.
RNA / Avidity Biosciences, Inc.
MRTX / Mirati Therapeutics, Inc.
EPIX / ESSA Pharma Inc.
BDSX / Biodesix, Inc.
BIO / Bio-Rad Laboratories, Inc.
GRPH / Graphite Bio, Inc.
VERV / Verve Therapeutics, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
ISEE / IVERIC bio Inc
MCRB / Seres Therapeutics, Inc.
GLTO / Galecto, Inc.
FBRX / Forte Biosciences, Inc.
JAZZ / Jazz Pharmaceuticals plc
GMTX / Gemini Therapeutics Inc
FOLD / Amicus Therapeutics, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
AVDL / Avadel Pharmaceuticals plc
GH / Guardant Health, Inc.
QTRX / Quanterix Corporation
HOLX / Hologic, Inc.
ARNA / Arena Pharmaceuticals Inc
AVTX / Avalo Therapeutics, Inc.
ADPT / Adaptive Biotechnologies Corporation
CNC / Centene Corporation
ARGX / argenx SE - Depositary Receipt (Common Stock)
BLSA / BCLS Acquisition Corp - Class A
SAGE / Sage Therapeutics, Inc.
BLU / Bellus Health Inc
KURA / Kura Oncology, Inc.
BAX / Baxter International Inc.
ACRS / Aclaris Therapeutics, Inc.
RGLS / Regulus Therapeutics Inc.
ITOS / iTeos Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
PTCT / PTC Therapeutics, Inc.
ALKS / Alkermes plc
PODD / Insulet Corporation